SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?


To: Cacaito who wrote (11297)8/17/1999 9:26:00 AM
From: dwight martin  Respond to of 17367
 
FWIW, Schwab apparently shows pre-opening trades now. XOMA is 4 1/2 by 4 7/16, appears fairly stable, and upwards of 80,000 shares have been traded.



To: Cacaito who wrote (11297)8/17/1999 9:32:00 AM
From: Abuckatatime  Read Replies (1) | Respond to of 17367
 
<Only the actual data could help.> Let the data speak...NOW! The damage is done. Who or what would be jeopardized if numbers are revealed?



To: Cacaito who wrote (11297)8/17/1999 9:37:00 AM
From: opalapril  Read Replies (1) | Respond to of 17367
 
So, this was the master PR plan Ellen said Xoma was working so hard on over the weekend?

I'm tempted to agree with Texas and Cacaito that Xoma should rescue the day by releasing some data, but I hold back for one reason: the thin and fraying thread of possibility, remote as it seems, that (1) Castello was telling the truth and (2) either Bloomberg misquoted Ellen or she blew it big time.

Either way shareholders are screwed big-time. Nothing new for Xoma, I guess. The only thing that can save the day now is FDA approval. Period. Based on what I know, I cannot agree that release of meaningful data would somehow screw up the BLA. But I have to assume (with rapidly diminishing confidence) that Castello knows more than I do. So rather than allay our anxieties, if you plan to stay long you have no choice but to go along with Castello.